References:
[1]. Access, O. (2012) Challenges in malaria research: Progress towards elimination Malaria surveillance systems: From control to elimination, 11, 1–78.
[2]. Akello, G. (2015). A History of Malaria Control in Uganda: The Limiting Effects of Political and Socio-Economic Inequality in Implementing Global Health Programs. Global Journal of Anthropology Research, 2 (July), 38–49. http://doi.org/10.15379/2410-2806.2015.02.01.04
[3]. Alilio, M. S., Bygbjerg, I. C., & Breman, J. G. (2004). Are multilateral malaria researches and control programs the most successful? Lessons from the past 100 years in Africa. American Journal of Tropical Medicine and Hygiene, 71(2 SUPPL.), 268–278.
[4]. Augustincic Polec, L., Petkovic, J., Welch, V., Ueffing, E., Tanjong Ghogomu, E., Pardo Pardo, J., … Tugwell, P. (2015). Strategies to Increase the Ownership and Use of Insecticide-Treated Bed nets to Prevent Malaria. Cochrane Database Syst Rev, 3(6), CD009186. http://doi.org/10.1002/14651858.CD009186.pub2
[5]. Breman, J. G., Alilio, M. S., & Mills, A. (2004). Conquering the intolerable burden of malaria: What’s new, what’s needed: A summary. American Journal of Tropical Medicine and Hygiene, 71(2 SUPPL.), 1–15. http://doi.org/71/2_suppl/1 [pii]
[6]. Briet, O. J. T., Chitnis, N., & Penny, M. (2012).Does mosquito mortality in WHO insecticide susceptibility tests relate to mosquito mortality in LLIN experimental hut studies? Malaria Journal, Conference (Suppl 1), S14. http://doi.org/10.1186/1475-2875-11-S1-O43
[7]. Briët, O. J. T., Chitnis, N., & Penny, M. (2012). Does mosquito mortality in WHO insecticide susceptibility tests relate to mosquito mortality in LLIN experimental hut studies? 11(Suppl 1), 2–3. http://doi.org/10.1186/1475-2875-11-S1-O43
[8]. Castor, J. P., Tuakli, J., MacLeod, B., & Kompala, C. (2012). Beyond the nets: Fighting malaria in the 21st century. Malaria Journal, Conference (Suppl 1), S47. http://doi.org/10.1186/1475-2875-11-S1-P74
[9]. Cotter, C., Sturrock, H. J. W., Hsiang, M. S., Liu, J., Phillips, A. A., Hwang, J., … Gosling, R. D. (2013). The changing epidemiology of malaria elimination: new strategies for new challenges. The Lancet, 382(9895), 900–911. http://doi.org/10.1016/S0140-6736(13)60310-4
[10].de Savignv, D. (2012). Health systems stewards and health systems researchers: a critical partnership for malaria elimination. Malaria Journal, 11 (Suppl 1), O13. http://doi.org/10.1186/1475-2875-11-S1-O13
[11].Ding, X. C., Ubben, D., & Wells, T. N. C. (2012). A framework for assessing the risk of resistance for antimalarials in development. Malaria Journal, 11(1), 292. http://doi.org/10.1186/1475-2875-11-292
[12].Esu, E., Ee, E., On, O., Uwaoma, A., & Mm, M. (2014). Artemether for severe malaria (Review). The Cochrane Database of Systematic Reviews, (9), 68. http://doi.org/10.1002/14651858.CD010678.pub2
[13].Foundation, M. G. (2018). The global effort to control malaria is making progress, but funding concerns, weak health. The Lancet Infectious Diseases, 17(1), 28–29. http://doi.org/10.1016/S1473-3099(16)30559-X
[14].Global technical strategy for malaria 2016–2030. (2016).
[15].Greenwood, B. (2014). Treatment of Malaria — A Continuing Challenge. New England Journal of Medicine, 371(5), 474–475. http://doi.org/10.1056/NEJMe1407026
[16].Guyatt, H. L., Corlett, S. K., Robinson, T. P., Ochola, S. A., & Snow, R. W. (2002). Malaria prevention in highland Kenya: Indoor residual house-spraying vs. insecticide-treated bednets. Tropical Medicine and International Health, 7(4), 298–303. http://doi.org/10.1046/j.1365-3156.2002.00874.x
[17].Health, M. O. F. (2014).Uganda Hospital and Health Centre IV Census Survey 2014.
[18].Hemingway, J., Ranson, H., Magill, A., Kolaczinski, J., Fornadel, C., Gimnig, J. … Foundation, M. G. (2016). Averting a malaria disaster: will insecticide resistance derail malaria control? 1785–1788. http://doi.org/10.1016/S0140-6736(15)00417-1
[19].Huho, B., Briët, O., Seyoum, A., Sikaala, C., Bayoh, N., Gimnig, J., Killeen, G. (2012). Consistently high baseline estimates for the proportion of human exposure to rural African malaria vector populations that occurred indoors, 11 (Suppl 1), 2875. http://doi.org/10.1186/1475-2875-11-S1-P50
[20].Kassam, R., Collins, J. B., Liow, E., & Rasool, N. (2015). A narrative review of the current context of malaria and management strategies in Uganda (Part I). Acta Tropica, 152, 252–268. http://doi.org/10.1016/j.actatropica.2015.07.028
[21].Killeen, G. F. (2013). A second chance to tackle African malaria vector mosquitoes that avoid houses and don’t take drugs. American Journal of Tropical Medicine and Hygiene, 88(5), 809–816. http://doi.org/10.4269/ajtmh.13-0065
[22].Kokwaro, G. (2009). Ongoing challenges in the management of malaria. Malaria Journal, 8Suppl 1(Suppl 1), S2. http://doi.org/10.1186/1475-2875-8-S1-S2
[23].Kyabayinze, D. J., Achan, J., Nakanjako, D., Mpeka, B., Mawejje, H., Mugizi, R. … Jean-Pierre, V. G. (2012). Parasite-based malaria diagnosis: are health systems in Uganda equipped enough to implement the policy? BMC Public Health, 12(1), 695. http://doi.org/10.1186/1471-2458-12-695
[24].Maire, N., Tarantino, M., Di Pasquale, A., Penny, M., & Smith, T. A. (2012). Cost-effectiveness of a malaria control programs in sub-Saharan Africa: Analysis of uncertainties using a stochastic individual-based simulation model. Malaria Journal, Conference (Suppl 1), S45–S46. http://doi.org/10.1186/1475-2875-11-S1-P68
[25].Mcintosh, H., Kl, J., Mcintosh, H., & Jones, K. L. (2010). Chloroquine or amodiaquine combined with sulfadoxine- pyrimethamine for treating uncomplicated malaria (Review) Chloroquine or amodiaquine combined with sulfadoxine- pyrimethamine for treating uncomplicated malaria, (4), 10–12. http://doi.org/10.1002/14651858.CD000386.pub2.Copyright
[26].Mshinda, H. (2012). The importance of the linkage between national and international research funders to support malaria elimination. Malaria Journal, 11 (Suppl 1), O4. http://doi.org/10.1186/1475-2875-11-S1-O4
[27].Mutero, C. M., Schlodder, D., Kabatereine, N., & Kramer, R. (2012). Integrated vector management for malaria control in Uganda: knowledge, perceptions and policy development. Malaria Journal, 11(1), 21. http://doi.org/10.1186/1475-2875-11-21
[28].Newby, G., Bennett, A., Larson, E., Cotter, C., Shretta, R., Phillips, A. A., & Feachem, R. G. A. (2016).The path to eradication: a progress report on the malaria-eliminating countries. The Lancet, 387(10029), 1775–1784. http://doi.org/10.1016/S0140-6736(16)00230-0
[29].Okia, M., Okui, P., Lugemwa, M., Govere, J. M., Katamba, V., Rwakimari, J. B. … Chanda, E. (2016). Consolidating tactical planning and implementation frameworks for integrated vector management in Uganda. Malaria Journal, 1–11. http://doi.org/10.1186/s12936-016-1269-7
[30].Olowe, O. A., Makanjuola, O. B., Olowe, R. A., Akintola, L., Day, S., & Hospital, A. (2015). Malaria in Africa and the Historical Perspective: The Journey so, 3(2006), 33–41.
[31].Opiyo, N., Yamey, G., & Garner, P. (2016). Subsidizing artemisinin-based combination therapy in the private retail sector (Review) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON, (3).
http://doi.org/10.1002/14651858.CD009926.pub2. www.cochranelibrary.com
[32].Pluess, B., Fc, T., Lengeler, C., Bl, S., Pluess, B., Tanser, F. C. … Sharp, B. L. (2010). Indoor residual spraying for preventing malaria (Review), (4). http://doi.org/10.1002/14651858.CD006657.pub2.Copyright
[33].Pm, G., Gelband, H., Graves, P. M., & Gelband, H. (2010). Vaccines for preventing malaria (pre-erythrocytic) (Review) Vaccines for preventing malaria (pre-erythrocytic), (4). http://doi.org/10.1002/14651858.CD006198.Copyright
[34].The region, A., Region, E. M., Region, E., & Region, S. A. (2015).Regional profile.
[35].Rica, C., & Salvador, E. (2013).World malaria report 2013 countries profile. World Health Organisation.
[36].Ringwald, P., Barrette, A., Rasmussen, C., & Newman, R. D. (2012).The global challenge of antimalarial drug resistance. Malaria Journal, Conference (Suppl 1), S12. http://doi.org/10.1186/1475-2875-11-S1-O37
[37].Road, L. (2014). THE UGANDA MALARIA REDUCTION STRATEGIC PLAN 2014-2020, (May), 1–83.
[38].Schwartz, L., Brown, G. V, Genton, B., & Moorthy, V. S. (2012). A review of malaria vaccine clinical projects based on the WHO rainbow table. Malaria Journal, 11(1), 11. http://doi.org/10.1186/1475-2875-11-11
[39].Talisuna, A. O., Grevval, P., Balyeku, A., Egan, T., Bwire, G., Piot, B. Jagoe, G. (2012). Overcoming the affordability barrier for effective and high-quality life-saving malaria medicines in the private sector in rural Uganda: the Consortium for ACT Private Sector Subsidy (CAPSS) pilot study, 11(Suppl 1), 6–7. http://doi.org/10.1186/1475-2875-11-S1-O16
[40].Talisuna, A. O., Noor, A. M., Okui, A. P., & Snow, R. W. (2015). The past, present and future use of epidemiological intelligence to plan malaria vector control and parasite prevention in Uganda. Malaria Journal, 14(1), 158. http://doi.org/10.1186/s12936-015-0677-4
[41].Tanner, M. (2012). The science of elimination in practice. Malaria Journal, Conference (Suppl 1), S18. http://doi.org/10.1186/1475-2875-11-S1-O53
[42].Tusting, L. S., Thwing, J., Sinclair, D., Fillinger, U., Gimnig, J., Bonner, K. E. … Lindsay, S. W. (2013). Mosquito larval source management for controlling malaria. The Cochrane Database of Systematic Reviews, 8(8), CD008923. http://doi.org/10.1002/14651858.CD008923.pub2
[43].Wells, T. N. C., & Wells T.N.C. (2012). New drugs for the control and elimination of malaria: A snapshot of the pipeline. Malaria Journal, Conference (Suppl 1), S10. http://doi.org/10.1186/1475-2875-11-S1-O31
[44].Wernsdorfer, W. H. (1984). Drug-resistant malaria. Endeavor, 8(4), 166–171. http://doi.org/10.1016/0160-9327(84)90080-2
[45].White, M., Conteh, L., Cibulskis, R., & Ghani, A. (2011). Costs and cost-effectiveness of malaria control interventions - a systematic review. Malar J, 10(1), 337. http://doi.org/10.1186/1475-2875-10-337